Ovation ScienceOVATF Net Margin % is -709.09% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 956 Drug Manufacturers companies, Ovation Science ranks worse than 96.65% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Ovation Science's Net Income for the
three
months ended in Mar. 2026 was $-0.08 Mil. Ovation Science's Revenue for the
three
months ended in Mar. 2026 was $0.01 Mil. Therefore, Ovation Science's net margin for the quarter that ended in Mar. 2026 was -709.09%.
The historical rank and industry rank for Ovation Science's Net Margin % or its related term are showing as below:
OVATF'
s Net Margin % Range Over the Past 10 Years
Min: -1311.29 Med: -552.27 Max: -158
Current: -933.33
OVATF's Net Margin % is ranked worse than 96.65% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs OVATF: -933.33
Ovation Science (OTCPK:OVATF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Ovation Science Net Margin % Related Terms
Ovation Science Net Margin % Historical Data
* Premium members only.
The historical data trend for Ovation Science's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ovation Science Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Net Margin % distribution charts can be found below:
* The bar in red indicates where Ovation Science's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ovation Science (OVATF) has a Net Margin % of -709.09% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Ovation Science and its competitors. According to the industry distribution chart, Ovation Science ranks #924 out of 956 companies in the Drug Manufacturers industry, placing it in the top 96.7%.
Is Ovation Science's Net Margin % too high?
Ovation Science's current Net Margin % is -709.09%. Based on the distribution chart, Ovation Science ranks #924 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Ovation Science's Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ovation Science ranks #924 out of 956 companies for Net Margin %. This places Ovation Science in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Ovation Science and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ovation Science's current Net Margin % is -709.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ovation Science stock overvalued right now?
Based on GuruFocus' analysis, Ovation Science (OVATF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.03, compared to a current price of $0.04 — trading 16.7% above its estimated fair value. The current Net Margin % is -709.09%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Ovation Science (OVATF), the current Net Margin % is -709.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ovation Science Inc. is a Canada-based company mainly engaged in the business of providing topical and transdermal cannabis products under the Ovation brand label, utilizing patented Invisicare delivery technology. The Company operates in one reportable operating segment, the sub-licensing and sales of cannabis products that utilize Invisicare, a patented polymer-based technology for topical and transdermal skin care products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OVATF has been successfully added to your 